| Product NDC: | 64661-070 |
| Proprietary Name: | J-MAX |
| Non Proprietary Name: | Dihydrocodeine Bitartrate, Guaifenesin |
| Active Ingredient(s): | 7.5; 100 mg/5mL; mg/5mL & nbsp; Dihydrocodeine Bitartrate, Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64661-070 |
| Labeler Name: | JayMac Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20080630 |
| Package NDC: | 64661-070-15 |
| Package Description: | 15 mL in 1 BOTTLE (64661-070-15) |
| NDC Code | 64661-070-15 |
| Proprietary Name | J-MAX |
| Package Description | 15 mL in 1 BOTTLE (64661-070-15) |
| Product NDC | 64661-070 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dihydrocodeine Bitartrate, Guaifenesin |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20080630 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | JayMac Pharmaceuticals |
| Substance Name | DIHYDROCODEINE BITARTRATE; GUAIFENESIN |
| Strength Number | 7.5; 100 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |